Loading...
FAQs
A-
A+

Fonts Size

Change Color

Hit enter to search or ESC to close
A-
A+

Fonts Size

Change Color

Alert:

Healthcare facilities are required to complete the Training Programme on Abu Dhabi Healthcare Guidelines for Health Media & Advertising System as mentioned in circular number 26/2023, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

484

Reviewed COVID-19
Research in Abu Dhabi

425

Approved Proposals

Approved COVID-19 Research by category

Epidemiological

224

Therapeutic

72

Diagnostic

140

COVID-19 Vaccine Trials

1.

Multicenter, Randomized, Double Blind, Parallel Placebo Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety and immunogenicity of Inactivated SARS-CoV-2 Vaccines in Healthy Population Aged 18 years old and above- Sinopham​

2.

A Phase III, Randomized, double-blind, placebo-controlled trial to evaluate Immunogenicity and Safety of the Gam-COVID-Vac combined vector vaccine in prophylactic Treatment for SARS-СoV-2 infection in the United Arab Emirates- SPUTNIK​

3.

“A Phase I/II Single-Blinded Randomised Safety and Immunogenicity Study in Adults of​ AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the​ Prevention of COVID 19- AstraZeneca​

4.

Post-Authorisation Efficacy and Safety Study (PAESS) (01_BIBP_PAESS): A Multicenter Observational Study of the Efficacy and Safety of the Inactivated SARS-CoV-2 Vaccine

5.

Post-Authorization Effectiveness and Safety Study (PAESS) (02_BIBP_PAESS): A Single Center Observational Study of the Effectiveness and Safety of the Inactivated SARS-CoV-2 Vaccine in Healthy Pediatric Population aged 3-17 years old​

6.

Clinical trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO cells) and Inactivated COVID-19 Vaccine (Vero cells) in Population aged 18 years and above.​

7.

A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Single Ascending Dose of PIKA Recombinant COVID-19 Vaccine in Healthy Adults, and Safety, Immunogenicity and Preliminary Efficacy of Multiple Ascending Doses of PIKA COVID-19 Vaccine in Adult Patients with Mild to Moderate COVID-19​

8.

A Phase III, Randomized, Double Blind, Placebo-Controlled International Multisite Clinical Trial in Parallel Assignment to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik Light Vector Vaccine in Adults in the SARS-CoV-2 Infection Prophylactic Treatment​

9.

Phase II Exploratory Clinical Trial (COVID-19-IVIG-201): A, Randomized, Double-blind, Placebo-controlled Phase II Exploratory Clinical Trial to Evaluate the Efficacy and Safety of Human COVID-19 Immunoglobulin (pH4) for Intravenous Injection in the Treatment of Patients with COVID-19​

10.

A Low Interventional Study to Evaluate the Protective Antibody Response to SARS-CoV-2 Inactivated Beijing Vaccine in Patients with Renal Failure and after Renal Transplantation

11.

Post-Authorisation Effectiveness and Safety Study (PAESS) (CoronaVac _PAESS): A Multicenter Observational Cohort Study of the Effectiveness and Safety of the Inactivated CoronaVac SARS-CoV-2 Vaccine

12.

A Phase III, Randomized, Double Blind, Placebo-Controlled International Multisite Clinical Trial in Parallel Assignment to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik Light Vector Vaccine in Adults in the SARS-CoV-2 Infection Prophylactic Treatment

13.

Clinical trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO cells) and Inactivated COVID-19 Vaccine (Vero cells) in Population aged 18 years and above

14.

Detection of COVID-19 and other respiratory diseases through Acoustery system, based on a machine analysis of cough, breathing and voice audio recordings

15.

A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Single Ascending Dose of PIKA Recombinant COVID-19 Vaccine in Healthy Adults, and Safety, Immunogenicity and Preliminary Efficacy of Multiple Ascending Doses of PIKA COVID-19 Vaccine in Adult Patients with Mild to Moderate COVID-19

16.

Post-Authorisation Effectiveness and Safety Study (PAESS) (02_BIBP_PAESS): A Single Center Observational Study of the Effectiveness and Safety of the Inactivated SARS-CoV-2 Vaccine in Healthy Pediatric Population aged 3-17 years old

17.

Phase II Exploratory Clinical Trial (COVID-19-IVIG-201): A, Randomized, Double-blind, Placebo-controlled Phase II Exploratory Clinical Trial to Evaluate the Efficacy and Safety of Human COVID-19 Immunoglobulin (pH4) for Intravenous Injection in the Treatment of Patients with COVID-19

18.

A Randomized, Controlled Phase I and Sequential Study to Evaluate the Safety and Immunogenicity following Immunization of GEN2-Recombinant COVID-19 vaccine (CHO cells) and Inactivated COVID-19 Vaccine (Vero cells) in Population Aged 18 Years and Above

Subscribe for updates

Thanks for Subscribing

Last updated: 18 Apr 2024

Mobile For an optimal experience please
rotate your device to portrait mode